Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Aug 1;38(4):316-321.
doi: 10.1097/WCO.0000000000001383. Epub 2025 May 21.

Brain age prediction from MRI scans in neurodegenerative diseases

Affiliations
Review

Brain age prediction from MRI scans in neurodegenerative diseases

Anthi Papouli et al. Curr Opin Neurol. .

Abstract

Purpose of review: This review explores the use of brain age estimation from MRI scans as a biomarker of brain health. With disorders like Alzheimer's and Parkinson's increasing globally, there is an urgent need for early detection tools that can identify at-risk individuals before cognitive symptoms emerge. Brain age offers a noninvasive, quantitative measure of neurobiological ageing, with applications in early diagnosis, disease monitoring, and personalized medicine.

Recent findings: Studies show that individuals with Alzheimer's, mild cognitive impairment (MCI), and Parkinson's have older brain ages than their chronological age. Longitudinal research indicates that brain-predicted age difference (brain-PAD) rises with disease progression and often precedes cognitive decline. Advances in deep learning and multimodal imaging have improved the accuracy and interpretability of brain age predictions. Moreover, socioeconomic disparities and environmental factors significantly affect brain aging, highlighting the need for inclusive models.

Summary: Brain age estimation is a promising biomarker for identify future risk of neurodegenerative disease, monitoring progression, and helping prognosis. Challenges like implementation of standardization, demographic biases, and interpretability remain. Future research should integrate brain age with biomarkers and multimodal imaging to enhance early diagnosis and intervention strategies.

Keywords: MRI; brain age; cognitive decline; machine learning; neurodegenerative diseases.

PubMed Disclaimer

Conflict of interest statement

J.C. is a shareholder in and advisor to Brain Key and Claritas HealthTech PTE.

Figures

Box 1
Box 1
no caption available
FIGURE 1
FIGURE 1
A high-level overview of a Brain Age prediction pipeline. Firstly, an MRI scan of an individual's brain is acquired. Next, the scan is input into a machine-learning model, previously trained on a large number of brain scan from healthy people and their age labels, and outputs the predicted age of the individual, the so-called ‘brain age’. The brain age is then compared to the chronological age of the individual; if the brain age is lower or equal to the chronological age, then the individual is healthy (attributed to high level of education, regular exercise, healthy diet and more). If the brain age is higher than the chronological age, then the individual is likely to have poorer brain health than expected for their age, potentially due to a disease process (for example, Alzheimer's disease, Parkinson's disease, frontotemporal dementia or another neurodegenerative disease).

Similar articles

References

    1. Liu W, Dong Q, Sun S, et al. Risk prediction of Alzheimer's disease conversion in mild cognitive impaired population based on brain age estimation. IEEE Trans Neural Syst Rehabil Eng 2023; 31:2468–2476. - PubMed
    1. Millar PR, Gordon BA, Luckett PH, et al. Multimodal brain age estimates relate to Alzheimer disease biomarkers and cognition in early stages: a cross-sectional observational study. Elife 2023; 12:e81869. - PMC - PubMed
    1. Antoniades M, Srinivasan D, Wen J, et al. Relationship between MRI brain-age heterogeneity, cognition, genetics and Alzheimer's disease neuropathology. EBioMedicine 2024; 109:105399. - PMC - PubMed
    1. Yoshinaga K, Matsushima T, Abe M, et al. Age-disproportionate atrophy in Alzheimer's disease and Parkinson's disease spectra. Alzheimers Dement (Amst) 2025; 17:e70048. - PMC - PubMed
    1. Beason-Held LL, Goh JO, An Y, et al. Changes in brain function occur years before the onset of cognitive impairment. J Neurosci 2013; 33:18008–18014. - PMC - PubMed

MeSH terms